PTCs-based Precision Treatment Strategy on Recurrent High-grade Gliomas

NCT05473923 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Recurrent High Grade Glioma

Interventions

DRUG: Receiving chemotherapeutic or targeted drugs recommended by molecular tumor board.

Sponsor

Beijing Tiantan Hospital

Collaborators

[object Object]